{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:41:30Z","timestamp":1783093290680,"version":"3.54.6"},"reference-count":29,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Various natural products have been demonstrated for their anti-tumor activities. As a natural\ntriterpenoid, the effects of ganoderic acid A on oxaliplatin chemotherapy for cancer treatment remain unclear.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A xenograft mouse model of colon cancer was constructed using the HT-29 cells. Ganoderic acid A was\nintravenously administered with or without oxaliplatin. The CCK-8 method was performed to assess cell viability.\nFlow cytometry was used to determine cell apoptosis and subtyping of T cells. Cytotoxicity of the T cells was assayed\nusing a lymphocyte-tumor co-culture system in vitro.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Ganoderic acid A enhanced tumor suppression of oxaliplatin in the xenograft model, while single administration\nshowed no obvious anti-tumor effect. Ganoderic acid A didn\u2019t affect cell proliferation and apoptosis of HT-29\ncells treated by oxaliplatin in vitro. Additionally, ganoderic acid A co-administered with oxaliplatin didn\u2019t impact T\ncell subtyping in the xenograft model. Cytotoxicity of T cells in co-administered mice was remarkably enhanced compared\nwith oxaliplatin-treated mice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our findings reveal that ganoderic acid A synergistically enhances tumor suppression of oxaliplatin possibly\nvia increasing the cytotoxicity of T cells.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520623666221103110934","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T07:22:43Z","timestamp":1667546563000},"page":"832-838","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ganoderic Acid A Enhances Tumor Suppression Function of Oxaliplatin via Inducing\nthe Cytotoxicity of T Cells"],"prefix":"10.2174","volume":"23","author":[{"given":"Chengkui","family":"Liu","sequence":"first","affiliation":[{"name":"Department\nof Gastrointestinal Surgery, Zibo Central Hospital, Gong Qing Tuan 54 Road, Zhangdian District, Zibo 255000, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Anorectal Surgery, The First Hospital of Zibo City, No. 4 Emeishandong Road, Zibo 255200, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Hospital of Zibo City, No. 4 Emeishandong Road, Zibo 255200, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Hospital of Zibo City, No. 4 Emeishandong Road, Zibo 255200, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Anorectal Surgery, The First Hospital of Zibo City, No. 4 Emeishandong Road, Zibo 255200, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00000421-199806000-00015","volume":"21","author":"deBraud F.","year":"1998","unstructured":"deBraud F.; Munzone E.; Nol&#xE8; F.; De Pas T.; Biffi R.; Brienza S.; Aapro M.S.; Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil. Am J Clin Oncol 1998,21(3),279-283","journal-title":"Am J Clin Oncol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"643824","DOI":"10.3389\/fmolb.2021.643824","volume":"8","author":"Branca J.J.V.","year":"2021","unstructured":"Branca J.J.V.; Carrino D.; Gulisano M.; Ghelardini C.; Mannelli D.C.L.; Pacini A.; Oxaliplatin-induced neuropathy: Genetic and epigenetic profile to better understand how to ameliorate this side effect. Front Mol Biosci 2021,8,643824","journal-title":"Front Mol Biosci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.canlet.2020.10.040","volume":"498","author":"Feng M.","year":"2021","unstructured":"Feng M.; Zhao Z.; Yang M.; Ji J.; Zhu D.; T-cell-based immunotherapy in colorectal cancer. Cancer Lett 2021,498,201-209","journal-title":"Cancer Lett"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.37175\/stemedicine.v1i4.49","volume":"1","author":"Yu J.","year":"2020","unstructured":"Yu J.; Jin J.; Li Y.; The physiological functions of IKK-selective substrate identification and their critical roles in diseases. STEMedicine 2020,1(4),e49","journal-title":"STEMedicine"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nrc3237","volume":"12","author":"Vanneman M.","year":"2012","unstructured":"Vanneman M.; Dranoff G.; Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 2012,12(4),237-251","journal-title":"Nat Rev Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"109529","DOI":"10.1016\/j.cbi.2021.109529","volume":"344","author":"Ma J.Q.","year":"2021","unstructured":"Ma J.Q.; Zhang Y.J.; Tian Z.K.; Anti-oxidant, anti-inflammatory and anti-fibrosis effects of ganoderic acid A on carbon tetrachloride induced nephrotoxicity by regulating the Trx\/TrxR and JAK\/ROCK pathway. Chem Biol Interact 2021,344,109529","journal-title":"Chem Biol Interact"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s12094-019-02240-6","volume":"22","author":"Das A.","year":"2020","unstructured":"Das A.; Alshareef M.; Henderson F.; Santos M.J.L.; Vandergrift W.A.; Lindhorst S.M.; Varma A.K.; Infinger L.; Patel S.J.; Cachia D.; Ganoderic acid A\/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth. Clin Transl Oncol 2020,22(7),1138-1145","journal-title":"Clin Transl Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1007\/s10753-021-01468-1","volume":"44","author":"Lu X.","year":"2021","unstructured":"Lu X.; Xu C.; Yang R.; Zhang G.; Ganoderic acid A alleviates OVA-induced asthma in mice. Inflammation 2021,44(5),1908-1915","journal-title":"Inflammation"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/jcb.24946","volume":"116","author":"Radwan F.F.Y.","year":"2015","unstructured":"Radwan F.F.Y.; Hossain A.; God J.M.; Leaphart N.; Elvington M.; Nagarkatti M.; Tomlinson S.; Haque A.; Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid. J Cell Biochem 2015,116(1),102-114","journal-title":"J Cell Biochem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e22392","DOI":"10.1002\/jbt.22392","volume":"33","author":"Cheng Y.","year":"2019","unstructured":"Cheng Y.; Xie P.; Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K\/AKT signaling pathway. J Biochem Mol Toxicol 2019,33(11),e22392","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-018-3485-7","volume":"456","author":"Gill B.S.","year":"2019","unstructured":"Gill B.S.; Navgeet; Kumar, S. Antioxidant potential of ganoderic acid in Notch-1 protein in neuroblastoma. Mol Cell Biochem 2019,456(1-2),1-14","journal-title":"Mol Cell Biochem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"6515","DOI":"10.3892\/ol.2018.9475","volume":"16","author":"Yang Y.","year":"2018","unstructured":"Yang Y.; Zhou H.; Liu W.; Wu J.; Yue X.; Wang J.; Quan L.; Liu H.; Guo L.; Wang Z.; Lian X.; Zhang Q.; Ganoderic acid A exerts antitumor activity against MDA MB 231 human breast cancer cells by inhibiting the Janus kinase 2\/signal transducer and activator of transcription 3 signaling pathway. Oncol Lett 2018,16(5),6515-6521","journal-title":"Oncol Lett"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nm.4296","volume":"23","author":"Piunti A.","year":"2017","unstructured":"Piunti A.; Hashizume R.; Morgan M.A.; Bartom E.T.; Horbinski C.M.; Marshall S.A.; Rendleman E.J.; Ma Q.; Takahashi Y.; Woodfin A.R.; Misharin A.V.; Abshiru N.A.; Lulla R.R.; Saratsis A.M.; Kelleher N.L.; James C.D.; Shilatifard A.; Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Nat Med 2017,23(4),493-500","journal-title":"Nat Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e0186250","DOI":"10.1371\/journal.pone.0186250","volume":"12","author":"Marmiroli P.","year":"2017","unstructured":"Marmiroli P.; Riva B.; Pozzi E.; Ballarini E.; Lim D.; Chiorazzi A.; Meregalli C.; Distasi C.; Renn C.L.; Semperboni S.; Morosi L.; Ruffinatti F.A.; Zucchetti M.; Dorsey S.G.; Cavaletti G.; Genazzani A.; Carozzi V.A.; Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights. PLoS One 2017,12(10),e0186250","journal-title":"PLoS One"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.sjbs.2019.07.005","volume":"26","author":"Ren L.","year":"2019","unstructured":"Ren L.; Protective effect of ganoderic acid against the streptozotocin induced diabetes, inflammation, hyperlipidemia and microbiota imbalance in diabetic rats. Saudi J Biol Sci 2019,26(8),1961-1972","journal-title":"Saudi J Biol Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejphar.2012.02.007","volume":"681","author":"Liu R.M.","year":"2012","unstructured":"Liu R.M.; Li Y.B.; Zhong J.J.; Cytotoxic and pro-apoptotic effects of novel ganoderic acid derivatives on human cervical cancer cells in vitro. Eur J Pharmacol 2012,681(1-3),23-33","journal-title":"Eur J Pharmacol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"600886","DOI":"10.3389\/fimmu.2020.600886","volume":"11","author":"Fidelle M.","year":"2020","unstructured":"Fidelle M.; Yonekura S.; Picard M.; Cogdill A.; Hollebecque A.; Roberti M.P.; Zitvogel L.; Resolving the paradox of colon cancer through the integration of genetics, immunology, and the microbiota. Front Immunol 2020,11,600886","journal-title":"Front Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/annonc\/mds074","volume":"23","author":"Jardim D.L.","year":"2012","unstructured":"Jardim D.L.; Rodrigues C.A.; Novis Y.A.S.; Rocha V.G.; Hoff P.M.; Oxaliplatin-related thrombocytopenia. Ann Oncol 2012,23(8),1937-1942","journal-title":"Ann Oncol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1111\/bph.13646","volume":"173","author":"McQuade R.M.","year":"2016","unstructured":"McQuade R.M.; Carbone S.E.; Stojanovska V.; Rahman A.; Gwynne R.M.; Robinson A.M.; Goodman C.A.; Bornstein J.C.; Nurgali K.; Role of oxidative stress in oxaliplatin\u2010induced enteric neuropathy and colonic dysmotility in mice. Br J Pharmacol 2016,173(24),3502-3521","journal-title":"Br J Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"102112","DOI":"10.1016\/j.ctrv.2020.102112","volume":"91","author":"Mauri G.","year":"2020","unstructured":"Mauri G.; Gori V.; Bonazzina E.; Amatu A.; Tosi F.; Bencardino K.; Ruggieri L.; Patelli G.; Arena S.; Bardelli A.; Siena S.; Sartore-Bianchi A.; Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities. Cancer Treat Rev 2020,91,102112","journal-title":"Cancer Treat Rev"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"118294","DOI":"10.1016\/j.lfs.2020.118294","volume":"260","author":"Yu T.","year":"2020","unstructured":"Yu T.; An Q.; Cao X.L.; Yang H.; Cui J.; Li Z.J.; Xiao G.; GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K\/AKT\/mTOR pathway. Life Sci 2020,260,118294","journal-title":"Life Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.biopha.2014.10.019","volume":"68","author":"Kozovska Z.","year":"2014","unstructured":"Kozovska Z.; Gabrisova V.; Kucerova L.; Colon cancer: Cancer stem cells markers, drug resistance and treatment. Biomed Pharmacother 2014,68(8),911-916","journal-title":"Biomed Pharmacother"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41401-020-0356-z","volume":"41","author":"Yu Z.","year":"2020","unstructured":"Yu Z.; Jia W.; Liu C.; Wang H.; Yang H.; He G.; Chen R.; Du G.; Ganoderic acid A protects neural cells against NO stress injury in vitro via stimulating &#x3B2; adrenergic receptors. Acta Pharmacol Sin 2020,41(4),516-522","journal-title":"Acta Pharmacol Sin"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/1753425912453187","volume":"19","author":"Rocca Y.S.","year":"2013","unstructured":"Rocca Y.S.; Roberti M.P.; Arriaga J.M.; Amat M.; Bruno L.; Pampena M.B.; Huertas E.; Loria F.S.; Pairola A.; Bianchini M.; Mordoh J.; Levy E.M.; Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients. Innate Immun 2013,19(1),76-85","journal-title":"Innate Immun"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/1479-5876-11-262","volume":"11","author":"Peng Y.P.","year":"2013","unstructured":"Peng Y.P.; Zhu Y.; Zhang J.J.; Xu Z.K.; Qian Z.Y.; Dai C.C.; Jiang K.R.; Wu J.L.; Gao W.T.; Li Q.; Du Q.; Miao Y.; Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer. J Transl Med 2013,11(1),262","journal-title":"J Transl Med"},{"key":"ref=26","first-page":"7","volume":"7","author":"Ling K.L.","year":"2007","unstructured":"Ling K.L.; Pratap S.E.; Bates G.J.; Singh B.; Mortensen N.J.; George B.D.; Warren B.F.; Piris J.; Roncador G.; Fox S.B.; Banham A.H.; Cerundolo V.; Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun 2007,7,7","journal-title":"Cancer Immun"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/925135","volume":"2012","author":"Luckheeram R.V.","year":"2012","unstructured":"Luckheeram R.V.; Zhou R.; Verma A.D.; Xia B.; CD4&#x207A;T cells: Differentiation and functions. Clin Dev Immunol 2012,2012,1-12","journal-title":"Clin Dev Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/iub.2461","volume":"73","author":"Fathi M.","year":"2021","unstructured":"Fathi M.; Pustokhina, I.; Kuznetsov, S.V.; Khayrullin, M.; Hojjat-Farsangi, M.; Karpisheh, V.; Jalili, A.; Jadidi-Niaragh, F. T\u2010cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer. IUBMB Life 2021,73(5),726-738","journal-title":"IUBMB Life"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.intimp.2014.08.001","volume":"23","author":"Que Z.","year":"2014","unstructured":"Que Z.; Zou F.; Zhang A.; Zheng Y.; Bi L.; Zhong J.; Tian J.; Liu J.; Ganoderic acid Me induces the apoptosis of competent T cells and increases the proportion of Treg cells through enhancing the expression and activation of indoleamine 2,3-dioxygenase in mouse lewis lung cancer cells. Int Immunopharmacol 2014,23(1),192-204","journal-title":"Int Immunopharmacol"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520623666221103110934","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/210600\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520623666221103110934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T10:28:15Z","timestamp":1680863295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/210600\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520623666221103110934","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-05-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}